You're here: My Science Blogging » Biotech » Article: A Lil’ Info About Breast Cancer

Genetic test for Herceptin infrequently used, study says.
A genetic test to determine if women should receive Roche’s (ROG.VX) breast cancer drug is frequently not given, U.S. researchers said on Monday. Up to two thirds of patients with aggressive breast cancer had no documentation of the test in their health insurance records, according to a study published online by the journal Cancer. The research also found that one in five genetic test results may be incorrect.
Further read to Reuters, readers?
Post to: delicious, Digg, ma.gnolia, Stumbleupon
Search only in this blog
Search across Asia Blogging Network
More? Go to Asia Blogging Network Column section.
cURL error 52: Empty reply from server
Ikuti diskusi, tuliskan komentar Anda.